François Blondel serves as the CEO and Managing Director of KitoZyme since January 2013 and has been the Executive Chairman of the Board and Founder of KiOmed Pharma since March 2014. Additionally, François is the Chairman of the Board and Co-founder of Biokuris and the Vice-Chairman of the Board and Co-founder of OncoDNA. François is also actively involved as a Director for Kazidomi, IntegraGen (an OncoDNA Group Company), and essenscia, and has held the position of Chairman of the Board at Wishbone Biotech until January 2024, as well as Director at Sopartec sa. François previously served as a Director for the Union Wallonne des Entreprises from March 2019 to August 2021.
Links